Article Details

Recursion's IPO set to be 2021's second highest

Retrieved on: 2021-04-16 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

Recursion's IPO set to be 2021's second highest. View article details on hiswai:

Excerpt

FDA approvals for biopharma products have reached their highest point in six years for a first quarter, while regulatory data is up a full 45% over last ...

Article found on: www.bioworld.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up